Do we need better prognostic factors in nodal-negative breast cancer? Contra.
Kaufmann
M
M
Department of Obstetrics and Gynaecology, Johann Wolfgang Goethe-University, Frankfurt, Germany. m.kaufmann@em.uni-frankfurt.de
Scharl
A
A
D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D008198:Lymph Nodes; D009367:Neoplasm Staging; D018579:Patient Selection; D011379:Prognosis; D016896:Treatment Outcome